Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Luisa Loiacono"'
Autor:
Felix M. Dobbs, Patrick van Eijk, Mick D. Fellows, Luisa Loiacono, Roberto Nitsch, Simon H. Reed
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Understanding how DNA double strand breaks (DSBs) form and are repaired in the genome depends on their accurate measurement. Here the authors describe INDUCE-seq; a DSB-detection method that simultaneously measures physiological and induced breaks th
Externí odkaz:
https://doaj.org/article/108e1aee16be4a13b26b44d7b4e2a047
Autor:
Mariangela De Robertis, Tommaso Mazza, Caterina Fusilli, Luisa Loiacono, Maria Luana Poeta, Massimo Sanchez, Emanuela Massi, Giuseppe Lamorte, Maria Grazia Diodoro, Edoardo Pescarmona, Emanuela Signori, Graziano Pesole, Angelo Luigi Vescovi, Jesus Garcia-Foncillas, Vito Michele Fazio
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-9 (2018)
Abstract EphB2 and EphA2 control stemness and differentiation in the intestinal mucosa, but the way they cooperate with the complex mechanisms underlying tumor heterogeneity and how they affect the therapeutic outcome in colorectal cancer (CRC) patie
Externí odkaz:
https://doaj.org/article/a4894f09e2574323b31d8cfe65188d20
Autor:
Ursa Lampreht Tratar, Luisa Loiacono, Maja Cemazar, Urska Kamensek, Vito Michele Fazio, Gregor Sersa, Emanuela Signori
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Cancer immunotherapy is currently one of the leading approaches in cancer treatment. Gene electrotransfer of plasmids encoding interleukin 12 (IL-12) into the cells leads to the production of IL-12, which drives immune cell polarization to an antitum
Externí odkaz:
https://doaj.org/article/adafbeca0d9c4413bfb7b72f718abbcd
Publikováno v:
Journal of Comparative Economics. 50:768-783
The spread of COVID-19 led countries around the world to adopt lockdown measures of varying stringency, with the purpose of restricting the movement of people. However, the effectiveness of these measures on mobility has been markedly different. Empl
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Supplementary Figure 2 - Patient characteristics in 6 cohorts analysed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8fcf9c2f21c1da3e4ddd4d3446b763
https://doi.org/10.1158/1078-0432.22466325
https://doi.org/10.1158/1078-0432.22466325
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Supplementary Figure 3 - Clinical characteristics of EphA2high and EphA2low patients in cohort 1 to 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d531d5cb849d8ad0f2a6b4bb881032
https://doi.org/10.1158/1078-0432.22466322
https://doi.org/10.1158/1078-0432.22466322
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Purpose: EphA2 receptor is involved in multiple cross-talks with other cellular networks, including EGFR, FAK, and VEGF pathways, with which it collaborates to stimulate cell migration, invasion, and metastasis. Colorectal cancer (CRC) EphA2 overexpr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cedf2ba265170d2f04ce3aa6490f44c
https://doi.org/10.1158/1078-0432.c.6526284
https://doi.org/10.1158/1078-0432.c.6526284
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Supplementary Table 3 - Univariate and multivariate analyses of factors affecting PFS in patients who received Cetuximab monotherapy belonging to EphA2high group (cohort 5, N=40).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2c75ed744e16eca6ec8ca9c36fe1a3
https://doi.org/10.1158/1078-0432.22466307
https://doi.org/10.1158/1078-0432.22466307
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Kaplan-Meier survival curves of EGFRhigh (dashed line) versus EGFRlow (solid line) for cohort 1, 2 and 3. P-values were calculated using log-rank tests. Tick marks represent censored data. Expression value thresholds for determining high and low grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ea1c9e604d8de0d23070fd31956f48
https://doi.org/10.1158/1078-0432.22466316
https://doi.org/10.1158/1078-0432.22466316
Autor:
Vito Michele Fazio, Jesus Garcia-Foncillas, Angelo Luigi Vescovi, Giuseppe Lamorte, Emanuela Signori, Luigi Marchionni, Massimo Sanchez, Tommaso Mazza, Maria Luana Poeta, Caterina Fusilli, Luisa Loiacono, Mariangela De Robertis
Supplementary Table 2A. KRAS mutational status vs. EphA2 expression (N = 70; P = 0.133{section sign}); 2B. Response rate vs. EphA2 expression (N = 68; P = 0.33{section sign}); 2C. Disease control rate vs. EphA2 expression (N = 68; P = 0.012{section s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3932972b9bd81a31f2937054cf9cb21
https://doi.org/10.1158/1078-0432.22466310.v1
https://doi.org/10.1158/1078-0432.22466310.v1